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Abstract
In eukaryotic cells, intracellular protein breakdown is mainly
performed by the ubiquitin–proteasome system. Proteasomes are
supramolecular protein complexes formed by the association of
multiple sub-complexes and interacting proteins. Therefore, they
exhibit a very high heterogeneity whose function is still not well
understood. Here, using a newly developed method based on the
combination of affinity purification and protein correlation profil-
ing associated with high-resolution mass spectrometry, we
comprehensively characterized proteasome heterogeneity and
identified previously unknown preferential associations within
proteasome sub-complexes. In particular, we showed for the first
time that the two main proteasome subtypes, standard protea-
some and immunoproteasome, interact with a different subset of
important regulators. This trend was observed in very diverse
human cell types and was confirmed by changing the relative
proportions of both 20S proteasome forms using interferon-c. The
new method developed here constitutes an innovative and power-
ful strategy that could be broadly applied for unraveling the
dynamic and heterogeneous nature of other biologically relevant
supramolecular protein complexes.
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Introduction
The proteasome is a supramolecular protein machinery that is
central to protein homeostasis. In all eukaryotic cells, it is involved
in the selective degradation of most short-lived intracellular proteins
(Hershko & Ciechanover, 1998; Glickman & Ciechanover, 2002),
ensuring subtle modulation of gene expression, but also the removal
of misfolded, aberrant (i.e. oxidized or mutated), or otherwise
damaged proteins, avoiding cytotoxicity. In higher eukaryotes, it is
critical to the immune response because it generates antigenic
peptide precursors that can be recognized by cytotoxic T lympho-
cytes (CTLs) on MHC class I molecules.
Proteasome particles are formed by the dynamic association of
several sub-complexes, a 20S core particle (20S CP), either single or
associated with one or two regulatory particles (RPs) of identical or
different protein composition. Proteasome complexes thus display a
high degree of heterogeneity. The 20S CP presents a a7b7b7a7
barrel-like structure and was shown to exist in the eukaryotic cell as
four different subtypes, depending on the subsets of incorporated
catalytic beta subunits. In the standard proteasome (sP20S), the two
b rings each contain three standard catalytic subunits, b1, b2, and
b5, which are replaced by distinct immunosubunits, b1i, b2i, and
b5i, in the immunoproteasome (iP20S), respectively. Two intermedi-
ate 20S CP subtypes, b5i 20S proteasome (b5i P20S) and b1ib5i 20S
proteasome (b1ib5i P20S), bearing a mixed incorporation of stan-
dard and immunosubunits, b1, b2, b5i and b1i, b2, b5i, respectively,
have also been identified in a wide range of cell types and tissues
(Guillaume et al, 2010). The catalytic subunits are responsible for the
three proteasome proteolytic activities (trypsin like, chymotrypsin
like, and caspase like), which can be modulated by the replacement
of standard subunits by immunosubunits (Orlowski & Wilk, 2000;
Basler et al, 2013). The iP20S is induced during the immune
response in mammals but also exists in various amounts as
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constitutive proteasome complexes, depending on tissues or cell type
(Dahlmann et al, 2000; Zoeger et al, 2006; Klare et al, 2007;
Bousquet-Dubouch et al, 2008; Guillaume et al, 2010, 2012). The
two a rings are located at the opposite ends of the proteolytic cavity
and regulate the access of substrates to catalytic sites through gated
pores of 13 A˚ in diameter. In mammals, gate opening can be effi-
ciently triggered through the association of the 20S CP with four main
different RPs, the 19S regulatory particle (19S RP), PA28ab, PA28c
(otherwise known as 11S RPs), and PA200. One 20S CP can interact
at its two sides with either two identical regulators or two different
ones, thus forming hybrid proteasomes (Tanahashi et al, 2000). The
most studied regulator, the 19S RP, is involved in the recognition, the
unfolding, and the translocation of poly-ubiquitinated substrates into
the 20S CP for degradation. In addition to the 19S RP, PA28ab and
PA28c RPs are abundant 20S proteasome-associated regulators pres-
ent in the cytosol and the nucleus, respectively (Drews et al, 2007;
Fabre et al, 2013). They catalyze protein degradation through an
ubiquitin-independent pathway, which still needs to be completely
clarified (Stadtmueller & Hill, 2011; Kish-Trier & Hill, 2013).
Although the binding constants between the different 20S
subtypes and its different RPs are not known, the binding mode
between the a-ring and RPs has been established precisely by
numerous structural studies and was found to be shared among
species (Stadtmueller & Hill, 2011; Beck et al, 2012; da Fonseca
et al, 2012; Lander et al, 2012; Lasker et al, 2012; Kish-Trier & Hill,
2013). In all cases, it involves the C-termini of RP subunits and a
pocket at the interface between a-subunits. Recently, in-solution
NMR surveys have evidenced an allosteric pathway linking the
binding sites of C-termini of the 11S RP with the active sites of the
Thermoplasma acidophilum 20S CP, emphasizing a clear connection
between these regions that are 80 A˚ apart. In particular, the modifi-
cation of active sites in the T. acidophilum CP was shown to induce
structural changes at the a-ring binding interface (Ruschak & Kay,
2012). This clearly suggests that changes in active sites configura-
tions, as found in sP20S and iP20S, might affect binding affinities
for RPs. It would thus be of great interest to characterize proteasome
heterogeneity and to determine whether preferential associations
within proteasome sub-complexes do exist.
Affinity purification coupled to mass spectrometry (AP-MS) is a
very powerful and sensitive approach for the determination of
protein complexes composition through the specific capture of a
target protein and all associated partners (Gingras et al, 2007;
Trinkle-Mulcahy et al, 2008; Glatter et al, 2009). A few studies take
advantage of the quantitative nature of affinity purification associ-
ated with mass spectrometry (AP-MS) data to define network archi-
tecture (Choi et al, 2010; Lee et al, 2011). However, in most cases,
interactome approaches using multiple baits are performed in a
given biological context. Moreover, they cannot easily resolve the
distribution of a protein of interest among the different complexes
in which it might be embedded (Zaki & Mora, 2014). System-wide
studies of the composition and dynamics of protein complexes have
recently been addressed using an alternative method to AP-MS,
protein correlation profiling associated with mass spectrometry
(PCP-MS). This approach involves biochemical fractionation proce-
dures and allows the assignment of proteins to specific organelles
(Andersen et al, 2003; Foster et al, 2006; Gatto et al, 2010) or, more
recently, to protein complexes (Kristensen et al, 2012), by
comparing the proteins elution profiles acquired by quantitative MS.
As far as interactome studies are concerned, PCP-MS increases the
analysis throughput of protein complexes dynamics (Kristensen
et al, 2012) and also helps monitoring the impact of subunit isoforms
or post-translational modifications in multiprotein complexes
(Kirkwood et al, 2013). Interestingly, the heterogeneity of protea-
somes can, at least in part, be resolved using PCP-MS on size exclu-
sion chromatography (SEC)-separated protein complexes because
this approach is able to distinguish and quantify the relative propor-
tions of singly and doubly capped 20S CPs (Kristensen et al, 2012).
The aim of the present study was to decipher proteasome hetero-
geneity through modern label-free quantitative proteomics. Using
PCP-MS on glycerol gradient-separated proteasome complexes, we
could first reveal a previously unreported preferential association of
immunoproteasome (iP20S) with the PA28ab RP. Then through the
development of a new workflow combining PCP-MS and AP-MS, we
could increase the sensitivity of detection of proteasome regulators
and thus go deeper into proteasome characterization. Indeed, by
correlating proteins abundances across a large set of 24 proteasome
samples immunopurified from nine different human cell lines, we
observed that the two main 20S proteasome subtypes, sP20S and
iP20S, interact with a different subset of regulators. Some of these
preferential interactions were validated by artificially or physiologi-
cally changing the proportions of both 20S CP subtypes in assem-
bled proteasomes. This novel integrated proteomic workflow
provides a valuable tool to better understand the dynamic and
complex nature of molecular systems.
Results
PCP-MS analysis of glycerol density gradient-separated
proteasome complexes
In a first attempt to resolve proteasome complexes heterogeneity
and identify components of the different proteasome subtypes, we
performed a PCP-MS analysis on U937 AML cell proteins separated
by glycerol density gradient ultracentrifugation (Fig 1A). This cell
line is particularly well suited for the analysis of proteasome diver-
sity because it contains equal amounts of each 20S proteasome
subtype and, in particular, very similar quantities of b5 and b2i cata-
lytic subunits (Fabre et al, 2013), which are uniquely found in
sP20S and iP20S complexes, respectively (Guillaume et al, 2010).
To maintain proteasome integrity throughout the purification
process, cells were cross-linked in vivo with formaldehyde. After cell
lysis, low-MW proteins (below 100 kDa) were discarded by ultrafil-
tration so that a high-quality separation of high-MW protein
complexes could be performed on a glycerol density gradient.
Proteins participating in the different complexes resolved in each
fraction of the density gradient were then identified and quantified
using high-resolution mass spectrometry analysis coupled online to
liquid chromatography. Label-free quantification based on peptide
ion extracted chromatograms was performed (Mouton-Barbosa
et al, 2010; Gautier et al, 2012) using the TOP3 quantification
method (Silva et al, 2006). A protein abundance index (PAI) was
calculated to approximate the relative quantity of each proteasome
subunit and proteasome-associated protein. To handle the inter-run
signal variations, heavy internal standards, composed of eight
peptides containing isotopically labeled arginine or lysine and
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eluting all along the chromatographic gradient, were added into
each sample before injection. A MS-based intensity profile could
therefore be obtained for the 3,353 proteins identified and quantified
in the 19 fractions of two biological replicates (Supplementary Table
S1). The profiles obtained for the 16 identified subunits of the 19S
regulator (Rpt1–6, Rpn1–3, Rpn5, 7–9, 11–13) (Fig 1B, left panel)
and for the 11 different non-catalytic subunits of the 20S proteasome
(a1–a7, b3, b4, b6, and b7) (Fig 1C, left panel) showed a low
dispersion from their respective median profiles, validating the
method. Interestingly, the two median profiles of all subunits corre-
sponding to the 20S CP and the 19S RP were somewhat different, in
particular in low density fractions 13–16. The high signal detected
for the 20S subunits in this profile area corresponds to free 20S core
particle elution fractions (no 19S subunits detected) and confirms
our previous results showing that a large proportion of 20S protea-
some is present as a free particle in the U937 cell line (Fabre et al,
2013). To screen for possible protein interaction among the same
complexes, we calculated a relative Euclidian distance, defined in the
A
B
C
Figure 1. Protein correlation profiling (PCP) analysis of glycerol density gradient-separated proteasome complexes.
A PCP-MS strategy to identify proteins interacting with specific proteasome subtypes. U937 cells were cross-linked with formaldehyde and lysed, and proteins were
concentrated and ultrafiltrated on a 100 kDa cutoff device. Protein complexes were then separated on a 15–40% glycerol gradient. Each fraction of the gradient was
analyzed by nano-LC-MS/MS. Protein quantification was performed using the mean XIC of the three most intense validated peptides for each protein, after internal
standard calibration using a mix of 8 isotopically labeled peptides. The PCP analysis was performed as described in the Materials and Methods section.
B PCP analysis of the 19S regulatory complex. Protein abundance profiles of 16 proteins of the 19S RP (Rpt1–6, Rpn1–3, Rpn5, 7–9, 11–13, gray lanes) and of their
median abundance (black lane) (left panel). PCP analysis is performed by plotting the v2 values (representing the Euclidian distance between the abundance profile of
each protein and the reference profile) of the experimental replicate 2 as a function of the v2 values of the experimental replicate 1 (middle left panel). The median
profile of the 19S complex subunits was used as the reference profile for the calculation of the v2 values. Different zooms of the graph are represented (middle right
and right panels). Light gray dots represent the proteins quantified in all the fractions of the density gradient and blue dots represent 19S subunits (right panel).
C PCP analysis of proteasome 20S complex. Protein abundance profiles of 17 proteins of the 20S CP (a1–a7, b1–b7, b1i, b2i, b5i, gray lanes) and of their median
abundance (black lane) (left panel). PCP analysis is performed by plotting the v2 values of the experimental replicate 2 as a function of the v2 values of the
experimental replicate 1 (middle left panel). The median profile of the 20S complex subunits was used as the reference profile for the calculation of the v2 values.
Different zooms of the graph are represented (middle right and right panels). Light gray dots represent the proteins quantified in all the fractions of the density
gradient and red dots represent 20S subunits.
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experimental section and called v2, between a reference profile and
the profile of all the proteins identified in the gradient. This statistical
method has proven its efficiency for comparison of sedimentation
protein profiles in quantitative proteomic experiments (Andersen
et al, 2003; Wiese et al, 2007). The distances obtained from two
independent gradient experiments performed on two biological repli-
cates were then plotted to further increase the confidence in protein
complexes assignments. When the 19S median profile was taken as
reference, all subunits from this protein complex exhibited low v2
values, under 0.05, and were accordingly gathered in an area very
close to the origin of the graph (Fig 1B, middle and right panels).
Usp14, a known 19S interacting deubiquitinating enzyme, was also
observed at a very close distance (mean v2 = 0.09), as expected
(Fig 1B, right panel). We then applied the PCP-MS analysis to 20S
proteasome subunits and observed that the 20S subunits distribution
could be clearly distinguished from the other proteins identified in
the gradient fractions (Fig 1C, 3rd panel). Unexpectedly, the 20S
immunocatalytic b2i subunit was the only 20S subunit observed at a
very high distance from the other 20S subunits (mean v2 = 3.5)
(Fig 1C, 2nd panel). However, a close correlation was evidenced with
both the PA28a and PA28b subunits of the PA28ab complex, when
the latter was taken as reference profile (Fig 2A). The b2i immuno-
catalytic subunit is by far the protein showing the closest profile to
that of PA28ab, when compared to all the proteins quantified in the
U937 glycerol sedimented lysate (v2 mean value of 0.025) (Fig 2B
and C). As b2i is exclusively found in the iP20S (Guillaume et al,
2010), these data therefore suggest a so far unknown preferential
association between the PA28ab regulator and the iP20S.
The abundances of core subunits of proteasome sub-complexes
strongly correlate in nine different human cell lines
To confirm the preferential association between the PA28ab regu-
lator and the iP20S and to allow a deeper characterization of
proteasome complexes, proteasomes were affinity-purified from
nine different formaldehyde cross-linked cell lines and analyzed by
nano-LC-MS/MS, as previously described (Fabre et al, 2013).
Formaldehyde cross-linking was shown to be required to stabilize
the association of all regulatory particles with the 20S core particle
(Fabre et al, 2013). To reach the largest diversity of proteasome
complexes, we analyzed the proteolytic complex in a wide variety
of human cell lines, including hematopoietic and epithelial cell
lines of different origins and exhibiting high variations both in the
composition of catalytic subunits and in the stoichiometry of
bound regulators or other associated proteins. Very high 20S
proteasome purification yields (87  5%) could be obtained
(Supplementary Fig S1A). A protein abundance index (PAI) was
calculated for each proteasome subunit or proteasome-associated
protein identified in the immunopurified complexes obtained from
two or three biological replicates of each cell line (Fig 3A and
Materials and Methods section for details). Importantly, no averag-
ing of biological replicates was performed, to keep the experimen-
tal variability. The abundances thus obtained for each protein
were then compared pairwise with the ones of another protein,
called reference protein, across the 24 proteasome immunoprecipi-
tates (Fig 3A). The correlation between the abundances of two
pairwise proteins was estimated using the coefficient of determina-
tion (R2), which is more stringent than the usually used Pearson’s
correlation coefficient (R) (Kirkwood et al, 2013). Interestingly,
when using the PAI as a relative abundance metric, very strong
correlations were obtained between subunits belonging to the
same complex, such as the 20S proteasome non-catalytic subunits
a6 and a7 (R2 = 0.98), the 19S regulator subunits Rpn1 and Rpn3
(R2 = 0.96) or the PA28a and PA28b subunits (R2 = 0.96) that
compose the PA28ab activator (Fig 3B–D). All 20S proteasome
non-catalytic subunits (a1–a7, b3, b4, b6, and b7) (gathered in a
group of proteins called ‘ncP20S’) or subunits belonging to the
19S regulator (Rpt1–6, Rpn1–3, 5–14) were pairwise compared and
A B C
Figure 2. Protein correlation profiling (PCP) analysis using the median profile of the PA28ab regulator as the reference profile.
A Profiles of the PA28a, PA28b, and the b2i proteins (blue, red and green lines, respectively).
B Plot of the v2 values of the experimental replicate 2 as a function of the v2 values of the experimental replicate 1.
C A zoom of the graph in (B) is represented and v2 coordinates for PA28a, PA28b, and b2i proteins are highlighted as blue, red, and green dots, respectively. Light gray
dots represent the v2 coordinates of the proteins quantified in all the fractions of the gradient. The median profile of the PA28a and PA28b subunits was used as the
reference profile for the calculation of the v2 values.
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very high coefficients of determination (0.90  0.07 and
0.93  0.04, respectively) were obtained (Supplementary Fig S1B),
demonstrating the efficiency of the AP-MS strategy used to corre-
late proteins belonging to the same complex. Moreover, the cellu-
lar expression levels of many 19S subunits and of some 20S
subunits are not correlated (Supplementary Fig S1D), contrary to
the abundances of these proteins in immunopurified proteasomes
(Supplementary Fig S1B), showing that the immuno-enrichment
step is required to highlight subunits interactions within a protein
complex.
Conversely, when plotting the PAIs of Rpn3 and PA28b, proteins
belonging to the 19S RP and the PA28ab regulator, respectively, a
much weaker correlation (R2 = 0.44) could be observed (Supple-
mentary Fig S3). This is probably because the 19S RP is involved in
several different types of functional proteasome complexes (30S,
26S for instance) in addition to hybrid proteasome (one 19S RP and
one PA28 RP associated with one 20S CP), which could indeed be
observed in U937 cells when immunopurifying PA28b (Supplemen-
tary Fig S1C).
These results therefore show that the protein abundance index,
associated with the R2, is able to quantitatively describe the correla-
tion of the relative abundances of proteins constituting core subun-
its of proteasome sub-complexes purified from a large set of human
cell lines exhibiting a high variety of proteasome complexes.
Comparing the abundances of the different proteasome subunits
and associated proteins in purified proteasome preparations there-
fore appears as an efficient approach to unravel putative binary
protein interactions among proteasome complexes.
Proteasome subunits and associated proteins cluster differently
on the basis of their abundances across the nine cell lines
To investigate further the composition of proteasome complexes
and highlight putative unknown interactions among specific protea-
some subunits or associated proteins, we pairwise compared, across
the biological replicates of the nine cell lines, the abundances of all
the identified proteins in the immunoprecipitates with the abun-
dances of eight important proteasome sub-complexes or regulators,
A
B C D E
Figure 3. Protein abundance correlation of affinity-purified complexes analyzed by mass spectrometry strategy applied to proteasome complexes.
A Proteasome complexes were immunopurified from nine formaldehyde-crosslinked human cell lines and analyzed by nano-LC-MS/MS. Protein abundance indexes
(PAIs) were used to represent the abundance of proteins in purified proteasome samples. The correlation between two different proteins was quantified using
coefficients of determination (R2).
B–E Correlations of abundances of a7 and a6 (B), Rpn3 and Rpn1 (C), PA28b and PA28a (D), and Rpn3 and PA28b (E).
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that we called ‘references’. These were the 19S, PA28ab, PA28c,
and PA200 activators, the PI31 proteasome regulator, the two major
20S proteasome subtypes, the sP20S (represented by the b5 catalytic
subunit) and the iP20S (represented by the b2i catalytic subunit;
Guillaume et al, 2010), and the ncP20S gathering the 20S non-
catalytic subunits (thus representing the total 20S proteasome). The
abundances of these different complexes were obtained by calculat-
ing the median PAI of their different subunits, as detailed in the
Materials and Methods section. Of the 170 human proteasome-
interacting proteins identified in previous AP-MS experiments
(Wang & Huang, 2008; Andersen et al, 2009; Bousquet-Dubouch
et al, 2009), 120 have been quantified in this survey and, among
these, 70 proteins exhibited a high correlation (R > 0.8) with at least
one of the references, suggesting that these proteins constitute reliable
proteasome partners. The R2 obtained between each reference and
these 70 major proteasome-associated proteins or subunits quanti-
fied in the nine cell lines proteasome preparations was used to
obtain hierarchical clusters, as detailed in the Materials and Meth-
ods section, which were then represented with a heat-map (Fig 4A).
The 20S assembly chaperones, proteasome assembly chaperones
(PACs) 1–4 and POMP, which were all detected in the AP-MS exper-
iments from the nine cell lines, were also included in this experi-
ment thus containing 73 proteins in total (Supplementary Table S2).
Using this supervised clustering approach, three major protein
clusters can be clearly highlighted. A first cluster is formed by
proteins whose abundances clearly correlate with those of the
ncP20S or the 19S RP references. These proteins gather all the non-
catalytic 20S subunits and 19S subunits, but also proteins which are
known to associate with the 19S RP-like USP14, a major deubiqu-
itinylase, and hHR23B and Ubiquilin-1, two proteins shuttling poly-
ubiquitinylated substrates to the 19S. A second cluster of proteins
was found to correlate with the sP20S, PA200, and PI31 references.
This protein group is composed of all the standard catalytic subunits
(b1, b2, and b5), PI31 and PA200 regulators, but also includes the
proteasome-associated proteins ECM29, Fbxo7, and UchL5. Of note,
PI31 and Fbox7 have been shown to dimerize although the func-
tional role of this interaction needs to be elucidated (Kirk et al,
2008). Finally, a third cluster gathers proteins correlating with the
iP20S and the PA28ab references. In this cluster are grouped all the
immunocatalytic subunits (b1i, b2i, and b5i) as well as the PA28a
and PA28b proteins. Strikingly, these proteins correlate very poorly
with the sP20S reference (R2 < 0.1), and moderately or poorly with
the ncP20S and the 19S (0.1 < R2 < 0.6). PA28c settles in this 3rd
cluster although it moderately correlates with the iP20S (R2 = 0.66)
and with PA28ab (R2 = 0.67).
To confirm these results, we used two complementary and unsu-
pervised statistical methods, the principal component analysis
(PCA) and the agglomerative hierarchical clustering (AHC), where
no reference proteins or protein groups were used to correlate the
abundances. Using both approaches, ncP20S, iP20S, and sP20S are
again found in three very distinct protein groups and cluster with
the same partners as those found with the supervised clustering
method (Fig 4B and Supplementary Fig S3A). Using the AHC,
PA28c is found in a different group as the iP20S and the PA28ab RP,
which are still found in the same cluster. Interestingly, UBE3C and
UCHL5, two proteasome-interacting proteins (PIPs) of antagonizing
ubiquitinating and deubiquitinating activities, respectively, are
found in the same cluster. The PCA also appeared to efficiently
cluster the group of proteasome assembly chaperones (PACs 1–4),
which could not be correlated with any of the references chosen in
the supervised hierarchical clustering statistical method. This might
be explained by the fact that these proteins interact with 20S protea-
some assembly intermediates and not with matured proteasome
forms. As these chaperones cluster with none of the 20S proteasome
types, our results suggest that none of the five 20S assembly chaper-
ones is specifically involved in the formation of a particular 20S
proteasome form.
Altogether, these results strongly suggest for the first time that
the associations between the proteasome 20S subtypes (ncP20S
representing total 20S proteasome, sP20S, iP20S), regulators (19S,
PA28ab, PA28c, PA200, PI31), and associated proteins (ubiquitinat-
ing and deubiquitinating enzymes, Ecm29, shuttling factors) do not
occur randomly and that preferential interactions exist within
proteasome complexes. Coupling AP-MS to protein correlation
profiling also allowed to more comprehensively characterize protea-
some heterogeneity because a much higher number of known
proteasome-interacting proteins (PIPs) were identified (120 PIPs) as
compared to the initial glycerol gradient analysis (where 73 PIPs
were identified).
Standard and immunoproteasome interact with a different
subset of proteins
An unexpected result emphasized by the clustering methods
presented above is that the two main 20S proteasome subtypes, the
sP20S and the iP20S (represented by the b5 and b2i catalytic subun-
its, respectively), partition in very different groups of proteins,
whatever the statistical approach used (Fig 4A and B; Supplemen-
tary Fig S2A). This result therefore suggests that sP20S and iP20S
interact with a different subset of proteins, in particular with distinct
regulators. In proteasome immunoprecipitates, the b5 subunit is
indeed highly correlated with PI31 and PA200 (R2 of 0.89 and 0.87,
respectively) but not with the PA28ab and PA28c complexes (R2 of
3105 and 0.06, respectively) (Supplementary Fig S2B). On the
other hand, the b2i subunit correlated well with the 20S protea-
some-associated PA28ab complex (R2 of 0.86) but very badly with
PA200 and PI31 (R2 of 0.01 and 0.03, respectively) (Supplementary
Fig S2B). Conversely, the 19S regulator does not correlate with any
of the two 20S proteasome subtypes as it exhibits almost identical
coefficients of determination for both the sP20S (R2 of 0.49) and the
iP20S (R2 of 0.44) (Supplementary Fig S2B). Its abundance is rather
correlated with the one of the ncP20S (R2 of 0.93), which represents
all 20S proteasome forms (Supplementary Fig S2B). This means that
the 19S RP associates as well with the sP20S as with the iP20S.
As far as the origin of the cell lines is considered, the three
lymphoid and myeloid cell lines (U937, KG1a, and NB4) display, as
expected, the highest amounts of immunoproteasome (the b2i
subunit corresponds to 10–30% of the total P20S) and P20S-associ-
ated PA28ab activator (Supplementary Fig S3C), and the lowest
fractions of standard proteasome (20–50% of the total P20S)
(Supplementary Fig S3A and B) and P20S-associated PA200 and
PI31 regulators, compared to the other cell lines.
Besides, expression controls show that the differential interac-
tions observed within proteasomes seem not be caused by higher or
lower expressions of the subunits forming these complexes (Supple-
mentary Fig S4 and Supplementary Table S3). To check more
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accurately this point, the expression levels of proteasome and RPs
subunits in the different cell lines were plotted (Supplementary Fig
S5A), as previously performed for subunits abundances measured
in proteasome immunoprecipitates (Supplementary Fig S2B and
Supplementary Table S3). Noteworthy, some of the correlations
measured in purified proteasomes were conserved in total cell
lysates (for instance, the good correlation between the 20S protea-
some a6 and a7 subunits, R2 = 0.8, or the one between PA28a and
PA28b, R2 = 0.8). However, many other subunits expression levels
could not be correlated, such as the ones among 19S subunits
(Supplementary Figs S1D and S5A) or, more importantly, the ones
between b2i and PA28ab (R2 = 0.37) and between b5 and PI31
(R2 = 0.15) (Supplementary Fig S5A). PA200’s expression level is,
however, correlated with the one of b5 (R2 = 0.82).
Next, to widen our correlation data to a larger group of puta-
tive proteasome-interacting proteins (PIPs), we correlated the
abundances of sP20S and iP20S with 193 proteins found confi-
dently associated with the purified proteasome, as these proteins
exhibit high correlation (R > 0.8) with at least one of the three
20S CP subtypes (total proteasome (ncP20S), sP20S, and iP20S).
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Figure 4. Protein abundance correlation of affinity-purified complexes analyzed by mass spectrometry analysis applied to the proteasome complexes and
their interacting proteins.
A Heat-map representing the correlations (expressed as the R2) between the abundances of 73 known proteasome-interacting proteins (PIPs) and the abundances of
8 reference proteins or protein complexes, PA28c, b2i (representing the iP20S), PA28ab, ncP20S (median of a1–a7, b3, b4, b6, and b7 profiles), 19S (median of Rpt1–6,
Rpn1–3, 5–14 profiles), PI31, b5 (representing the sP20S), and PA200. For protein complexes, the median PAI of their subunits in each of the 24 AP-MS experiments
was used: a1–a7, b3, b4, b6, and b7 subunits for the ncP20S, Rpt1–6, Rpn1–3, 5–14 for the 19S RP, and PA28a and PA28b subunits for the PA28ab RP. The R2 values
were hierarchically clustered. Three distinct clusters of composition detailed hereafter could be obtained. Cluster 1 (from top to bottom): Rpt3, Rpn13, a2, Rpn7,
USP14, hHR23B, a1, b6, b3, a4, a7, Rpn6, Rpn3, Rpt4, Rpn10, Rpn5, Rpt5, Rpn1, Rpn11, Rpt1, Rpn9, Rpn2, Rpn8, a3, a6, b4, Rpt6, PDC6, Rpn12, APEH, Ubiquilin-1, a5,
b7, CCT7, CCT4, CCT2, CCT3, CCT5, CCT6A, DNAJA1, HSP90AB1, HSP90AA1, PNP, Rpt2. Cluster 2 (from top to bottom): 14-3-3f/d, CAND1, GSR, UBE3C, b2, ATP5A1, ATP5B,
b1, PA200, b5, FBXO7, UCHL5, TXNL1, ECM29, PI31. Cluster 3 (from top to bottom): PA28b, PITH1, b2i, PA28a, PA28c, b5i, b1i.
B Principal component analysis (PCA) of the abundances of 73 known PIPs. The circles represent the main clusters observed (iP20S, ncP20S/19S, sP20S and the 20S
assembly chaperones).
C Plot of the R2 values between the iP20S or the sP20S and 193 protein correlating (R2 > 0.8) with the iP20S, the sP20S, or the ncP20S.
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These proteins could be quantified with at least two peptides and
display median signal-to-noise ratios above 10 (Supplementary
Table S4). Figure 4C shows the R2 obtained between all these
proteins and the sP20S or the iP20S. Strikingly, the curves appear
inverted, showing that proteins whose presence highly correlates
with the sP20S are not found associated with the iP20S, and vice
versa. Importantly, no such trend was observed in the total
lysates of the nine cell lines (at least for the 186 out of 193 puta-
tive PIPs which could be identified; Supplementary Table S4 and
Supplementary Fig S5B). In total, 60 putative PIPs correlate
(R > 0.8) with the sP20S and 31 do with the iP20S in the protea-
some immunoprecipitates (Fig 4C). These proteins therefore
constitute possible substrates or PIPs associating preferentially
with one particular 20S proteasome subtype.
To further confirm the preferential association of sP20S and
iP20S with a different subset of regulators, we next used two cell
lines expressing a unique form of these two 20S subtypes. Protea-
somes were affinity-purified from formaldehyde cross-linked HEK
EBNA cells, either untransfected (containing mainly sP20S) or trans-
fected with the three immunocatalytic subunits b5i, b1i and b2i, so
that these cells contain only iP20S (Fig 5A). Precipitates were
analyzed by nano-LC-MS/MS and quantified by the TOP3 label-free
quantitative method (Supplementary Table S5). In each sample, for
a given regulator (19S, PA28ab, PA28c, PA200, and PI31), the
protein abundance index was defined as the mean of the PAIs of all
the proteins belonging to this regulator and was normalized by the
PAI of the ncP20S, to obtain a normalized PAI. Then, the regulator’s
averaged (n = 4 biological replicates) normalized PAIs were set to 1
A
C
D
B
Figure 5. Changes in the expression of 20S proteasome catalytic subunits modulate 20S-associated regulators.
A The two HEK EBNA cell lines express only standard proteasome or immunoproteasome subunits. Western blots against the immuno- (b1i, b2i, b5i) and standard (b1,
b2, b5) catalytic subunits of the 20S proteasome. Calnexin is used as a loading control. Black lines delineate the boundary between vertically sliced images that
juxtapose lanes that were non-adjacent in the gel. Importantly, the bands were assembled from the same blot.
B Relative normalized abundance indexes of proteasome regulators in HEK EBNA cells containing only immunoproteasome compared to HEK EBNA cells containing
only standard proteasome. The normalized abundance indexes for each regulator were set to 1 for standard proteasome conditions (n = 4).
C Kinetics of IFN-c treatment on HeLa cells. HeLa cells were stimulated for 0, 24, 48, or 72 h with IFN-c. Western blots were performed on total cell lysates with
antibodies against the b2i, a2, and a5 subunits. IRF-1 was used to control IFN-c treatment efficiency, and GAPDH was used as a loading control.
D For each time point of the IFN-c treatment, proteasome complexes were purified and analyzed by LC-MS/MS. Proteasome complexes dynamics was measured by
label-free quantitative proteomics. The normalized abundance index of each protein or protein complex obtained at each time point was compared to the one
obtained at the 0 h time point to obtain a regulator relative normalized PAI (n = 3).
Data information: *P < 0.05; **P < 0.01; ***P < 0.001 (Student t-test).
Source data are available online for this figure
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for the cell lines containing the sP20S to obtain a regulator relative
normalized PAI. As shown in Fig 5B, using these two model cell
lines, we observe that the 19S, PA28c, and PA200 associate equally
with the sP20S and the iP20S. On the other hand, the interaction of
PA28ab with the iP20S is nearly fourfold higher than with the
sP20S, and the relative abundance of PI31 is increased by a factor
superior to 8 in the sP20S immunoprecipitate when compared to
that of iP20S. Interestingly, proteasome immunopurified from HEK
EBNA cells transfected with either b5i alone or with b1i and b5i
(Supplementary Fig S6A) (and therefore expressing a unique inter-
mediate P20S, b5i intermediate 20S proteasome (b5i P20S) or b1ib5i
intermediate 20S proteasome (b1ib5i P20S), respectively (Guillaume
et al, 2010)) associate with the same main P20S proteasome regula-
tors as the immunoproteasome (Supplementary Fig S6B). The pref-
erential association of PA28ab with the iP20S was further confirmed
by a Western blot analysis using another system of overexpression
of the immunocatalytic subunits (HEK T-Rex) (Supplementary Fig
S6C). Although PA28a and PA28b proteins were equally abundant
in the two cell lysates containing either the b5 subunit (representing
the sP20S) or the b2i subunit (representing the iP20S), the MCP21
immunoprecipitate of the iP20S showed a much higher quantity of
co-immunoprecipitated PA28a and PA28b proteins than the MCP21
immunoprecipitate of sP20S.
Finally, we took advantage of the ability of IFNc to physiologi-
cally change the relative proportions of sP20S and iP20S to validate
further the preferential association of sP20S and iP20S with a differ-
ent subset of regulators. HeLa cells, which contain a low level of
iP20S at basal state (Fabre et al, 2014a,b), were treated with IFNc
during 72 h. IRF1, the transcription factor responsible for the expres-
sion of the catalytic immunosubunits, was rapidly induced (Fig 5C),
which leads to a strong increase in the expression of all the catalytic
immunosubunits, and especially of b2i, together with a decrease of
the incorporation of the three standard catalytic subunits in the
proteasome complexes (Supplementary Fig S7A). More precisely,
the quantitative results show an eightfold increase of iP20S and a
twofold decrease of sP20S, while no significant change of the total
20S proteasome abundance was observed (no significant variations
of the a2 and a5 subunits, Fig 5C). Next, we quantified the dynamics
of 20S-associated 19S, PA28ab, PA28c, PA200, and PI31 regulators
under IFNc treatment, by analyzing the abundances of these protea-
some-associated proteins in immunopurified proteasomes at each
time point, as explained earlier (Fig 5D and Supplementary Table
S6). No significant variations of 19S and PA28c were noticed while
the trends of PA28ab on one hand and of PA200 and PI31 on the
other hand followed the ones of the iP20S and of the sP20S, respec-
tively. These differential interactions, in particular the ones involv-
ing PI31 and PA200, are not caused by changes of the expression of
these proteins in the total lysates of the IFNc-stimulated HeLa cells
(Supplementary Fig S7B and Supplementary Table S7). These results
thus strongly suggest that, in a physiological context where
significant variations of the sP20S and iP20S abundances are
observed, the quantities of some of the 20S-associated regulators
fluctuate in parallel to the quantities of sP20S or iP20S. Noteworthy,
PA200’s abundance is correlated with that of the sP20S both in the
nine cell lines and in the IFNc-stimulated HeLa cells, but not in the
HEK EBNA systems, which, however, constitutes a less physiologi-
cally relevant model. Altogether, these results clearly show for the
first time a preferential interaction of a subset of 20S proteasome
regulators, in particular PA28ab, PA200, and PI31, with either the
sP20S or the iP20S.
Recently, the in-depth proteomic profiling of human proteins
from tissue or cell lines samples from diverse origins was published
(Kim et al, 2014; Wilhelm et al, 2014). From the web-based
resource made freely available by Kim et al (Kim et al, 2014), we
could extract the heat-map representing the abundances of sP20S,
iP20S, PA28ab RP, PA200 RP, and PI31 in 30 histologically normal
samples from diverse tissues, either fetal or adult (Supplementary
Fig S8). As expected, iP20S and PA28ab are clearly overexpressed in
antigen-presenting cells. Strikingly, PI31’s expression is well corre-
lated with the abundance of sP20S, in particular in all the fetal
tissues studied. These results suggest a possible role of the associa-
tion of PI31 with the sP20S in fetal development. Interestingly, the
expression of PA200 is high and matches well that of sP20S in adult
reproductive tissues, but not in fetal ones. This result thus correlates
with a known important function of PA200 during spermatogenesis
(Khor et al, 2006). However, as demonstrated in this study using
AP-MS, correlated levels of expression between two protein
complex components do not necessarily involve their common inte-
gration within a complex.
Discussion
Proteasomes constitute dynamic structures with respect to the cellu-
lar environment, the cell type, the subcellular localization, the
tissue, or in response to physiological and external perturbations.
They adapt to these diverse biological contexts through changing
their overall subunit composition and association with diverse regu-
latory particles (RPs) and proteasome-interacting proteins (PIPs).
Proteasome diversity could thus reflect specialized functions of each
individual proteasome form. To address proteasome heterogeneity,
we set out to resolve the various complexes in which the different
20S CPs might be involved in. To support more generalized conclu-
sions, we used a large variety of human cell lines exhibiting
different proteasome compositions, as well as complementary
methodological approaches combining the sensitivity of AP-MS and
the resolving power of PCP-MS.
AP-MS is a global strategy that has efficiently revealed hundreds
of proteasome-associated proteins (PIPs) (Bousquet-Dubouch et al,
2011; Kaake et al, 2014) but that did not assign them to particular
20S proteasome subtypes. Alternatively, protein correlation profiling
associated with MS can distinguish different related sub-complexes.
A given protein might be assigned to a given complex through the
similarity of protein profiles across chromatographic fractions.
Recently, this approach has proven to be efficient for the determina-
tion of the quantitative distribution of the 19S RP among the singly
and doubly capped proteasome complexes using a high-resolution
SEC approach (Kristensen et al, 2012). In this work, 300 protein
complexes were identified from HeLa cells lysates using stringent
peak features computational filtering. However, given the high
dynamic range of mammalian cells proteins, only the most abun-
dant and stable subunits of a given protein complex might be identi-
fied and confidently clustered. Havugimana et al (2012) doubled the
depth of the analysis (622 putative protein complexes identified) but
at the cost of a high fractionation effort (more than 1,000 fractions
analyzed). The PCP-MS analysis we performed on U937 AML cells
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proteins separated by glycerol density gradient ultracentrifugation
enabled to reveal for the first time a previously unreported preferen-
tial association between iP20S and PA28ab RP. However, in the
19 glycerol gradient fractions analyzed, only the most abundant
proteasome regulators such as 19S, PA28ab, or PA28c could be
identified, probably because of the low fractionation level used.
Many of the other known PIPs were missing, probably because of
their sub-stoichiometric integration into proteasomes. So, as an
alternative to extensive fractionation, we developed a new workflow
combining the strengths of AP-MS and PCP-MS to significantly
increase the number of PIPs identified and thus to comprehensively
analyze proteasome complexes heterogeneity.
Contrary to all previous surveys where PCP-MS was applied on
elution profiles resulting from biochemical fractionation of protein
complexes arising from a unique biological sample, we used a new
strategy where the quantitative MS abundances of proteasome
subunits and associated proteins were compared across 24 affinity-
purified proteasome samples obtained from a wide range of nine
human cell lines exhibiting very diverse proteasome composition
(Fabre et al, 2014a,b). Although this approach is targeted to a
protein complex of interest and thus low throughput as compared to
the SEC-based PCP-MS strategy, it allows going deeper into the
characterization of a heterogeneous protein complex such as the
proteasome. As previously reported using PCP-MS on chromato-
graphic elution profiles (Kristensen et al, 2012; Kirkwood et al,
2013), we assumed that two proteins that are always present
together in the same complex have similar abundance patterns in
the affinity-purified samples. Using independent supervised and
unsupervised statistical approaches, hierarchical clustering and
principal component analysis, respectively, proteasome subunits
and interacting proteins were clustered according to their abun-
dances in the 24 proteasome immunoprecipitates. Interestingly, core
subunits of known proteasome sub-complexes, such as the 19S or
the PA28ab RPs, expectedly partition into the same group, which
emphasizes the quality of the data but also the relevance of the
statistical approaches.
Two main forms of functional 20S proteasomes are present in
higher eukaryotes, the standard proteasome (sP20S) and the immu-
noproteasome (iP20S), that differ by their three beta catalytic
subunits and that share the seven alpha and the four other beta
subunits. We arbitrarily called in this study 20S non-catalytic protea-
some (ncP20S) as the subset of the 11 common proteins (a1–a7, b3,
b4, b6, and b7), which are present in all 20S proteasome forms;
ncP20S thus represents the total 20S core particle. A protein that
will be associated with the two functional 20S proteasome forms
will correlate with subunits of the ncP20S, while a protein that will
be preferentially associated with the sP20S or with the iP20S will
correlate with the b5 subunit or with the b2i subunit, respectively.
An unexpected and striking result arising from the statistical analy-
sis of the data was that the 20S subunits can be clustered into three
different groups in which the ncP20S, the iP20S, and the sP20S
clearly emerge as favorite partners of distinct subsets of proteins,
and in particular to different important 20S CP regulators, such as
the 19S RP, the PA28ab RP, and the PA200 and PI31 proteins,
respectively. These preferential associations were further confirmed
by changing the relative proportions of the two 20S CP subtypes,
either using model cell lines containing a unique subtype of 20S
proteasome, or physiologically, by IFNc stimulation.
Altogether, our data demonstrate, through the different
approaches used, that the 19S RP does not have any preference to
any of the two sP20S and iP20S subtypes. This probably emphasizes
the ubiquitous role of the 19S RP, a very broadly conserved protea-
some activator (Stadtmueller & Hill, 2011) which is indeed the
only proteasome-associated regulator required for the ubiquitin-
dependent protein degradation pathway, a system involved in all
major cellular processes of eukaryotic organisms.
On the contrary, PA28a and PA28b subunits are clustered with
the 3 beta catalytic immunosubunits. The iP20S associated with the
PA28ab RP thus represents a functional subclass of proteasome
complex. The two subunits constituting the PA28ab RP are IFNc
inducible, and, consistent with this property, many studies have
implicated PA28ab in the efficient production of MHC class I ligands
both in vitro and in vivo (Dick et al, 1996; Groettrup et al, 1996,
2010; Schwarz et al, 2000). However, the mechanistic basis for this
function remains elusive. The primary actor of IFNc-induced epitope
generation is the iP20S because its cleavage specificity is different
from the one of the sP20S and may favor the generation of antigenic
peptides sequences which can be loaded on MHC class I molecules
(Romero et al, 1991; Toes et al, 2001; Basler et al, 2013). The
preferred interaction we observed between iP20S and PA28ab might
at least in part explain the positive effect of PA28ab on the CTL
response, in particular in the early IFNc-stimulating phase, when
newly assembled iP20S is not abundant. Indeed, the preferential
incorporation of b1i, b2i, and b5i inducible subunits into newly
assembled 20S proteasome takes time, at least 8–12 h (Seifert et al,
2010), and the ability of PA28ab to modulate the quantity but also
the quality of peptide repertoire produced by the 20S proteasome
(Dick et al, 1996; Shimbara et al, 1997; Cascio, 2014; Raule et al,
2014) might therefore trigger an effective and rapid CTL response.
How the binding of PA28ab to the 20S proteasome could affect
proteasome activity and cleavage specificity was recently studied by
in solution NMR spectroscopic analysis of the archaeal T. acidophi-
lum 20S proteasome bound to the 11S RP (PA26) (Ruschak & Kay,
2012). CP catalytic proteolysis was indeed shown to be controlled
and modulated through allosteric mechanisms by which 11S binding
is communicated to active sites distant of about 75 A˚. Another
biological role that is common to both iP20S and PA28ab (Seifert
et al, 2010) resides in their general protective function from oxida-
tive stress in several biological contexts (Pickering et al, 2010;
Seifert et al, 2010; Li et al, 2011a,b; Hernebring et al, 2013). Our
findings concerning the preferred association of iP20S and PA28ab
could explain the observed enhanced activity of iP20S to clear the
defective ribosomal products generated during IFN-induced oxida-
tive stress (Seifert et al, 2010) and, more generally, could account
for their common role in the maintenance of protein homeostasis in
oxidant conditions.
Our results strongly suggest that PI31 associates preferentially
with sP20S and much less with iP20S in a wide range of human
cell lines. PI31 was first described as a natural 20S proteasome
inhibitor in vitro (McCutchen-Maloney et al, 2000), but this func-
tion was not confirmed in vivo (Zaiss et al, 2002) and the regula-
tory role of PI31 on the proteasome still remains unclear (Li et al,
2014). Whether a functional link between sP20S and PI31 would
account for the repression of IFNc-induced iP20S maturation
exerted by PI31 (Zaiss et al, 2002) could be the subject of further
investigation.
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Another important consideration to be addressed is the structural
basis of the preferential association of sP20S and iP20S with a differ-
ent subset of 20S regulators. Recent biochemical studies have
demonstrated that modification at the active sites leads to long
distance gate opening (Osmulski et al, 2009) and to changes in bind-
ing affinities for RPs (Kleijnen et al, 2007). Therefore, this suggests
that the replacement of the b1, b2, and b5 subunits of the sP20S by
their immunocounterparts b1i, b2i, and b5i in the iP20S could
modulate RPs binding. The allosteric effect described by Ruschak
and Kay (2012) might well be operative in more complex CPs
because of the high interspecies conservation of CPs mechanism of
proteolysis and RPs binding (Stadtmueller & Hill, 2011). We there-
fore believe that the structural differences at the active sites of
human sP20S and iP20S might well account for the fact that they
interact with a different subset of proteins, and more precisely with
different RPs such as PA28ab, PA200 or PI31. Noteworthy, PA200
and Ecm29 are both large monomeric proteins that interact with the
a rings via their HEAT repeat domain (Savulescu & Glickman,
2011). This structural similarity might explain their common
preferred association with the sP20S subtype.
Besides 73 well-characterized proteins of the proteasome
complexes, this study allowed to identify 123 additional proteins
whose abundance correlated with one of the two major 20S CPs,
sP20S and iP20S, or with the ncP20S. Unexpectedly, they could also
be clustered in three groups equally distributed between iP20S and
sP20S, or preferentially associated with one of the two. This
unequal distribution suggests that these proteins are not contami-
nants of the immunopurified proteasome fractions but are func-
tional players or proteasome substrates.
More generally, the presented strategy could be widened to
unravel the dynamic and heterogeneous nature of many other
biologically relevant molecular systems.
Materials and Methods
Cell lines and culture conditions
HEK 293T, HCT116, RKO, and U2OS cell lines were grown in DMEM
media supplemented with 10% fetal bovine serum (FBS). U937,
HeLa S3, and NB4 cell lines were grown in RPMI 1640 media
supplemented with 10% FBS. KG1a cell line was grown in RPMI
1640 media supplemented with 20% FBS. MRC5 cell line was grown
in MEM-a media supplemented with 10% FBS. All cell lines were
cultured with 2 × 103 M glutamine, 100 Units/ml penicillin,
100 lg/ml streptomycin at 37°C, and 5% CO2. Unsynchronized cells
were harvested at 80% of confluence for adherent cells or at a
concentration of 1 × 106 cells per ml of culture for suspension cells.
HEK EBNA and HEK T-Rex cells were grown as described elsewhere
(Chapiro et al, 2006; Guillaume et al, 2010). HeLa cells were treated
with interferon-c (R&D Systems, Minneapolis, MN, USA) at a
concentration of 100 ng/ml in fresh medium.
Formaldehyde in vivo cross-linking, and proteasome purification
and quantification
Formaldehyde in vivo cross-linking was performed with a concen-
tration of 0.1% at 37°C during 15 min. The cross-linking reaction
was quenched with addition of 125 mM of glycine, and cells were
washed three times with PBS and stored at 80°C. Cells were lysed
with 2 ml of lysis buffer (10 mM Hepes pH 7.9, 10 mM KCl, 5 mM
MgCl2, 10% glycerol, 10 mM ATP, 1% NP-40, protease and
phosphatase inhibitor; Roche) for 15 min at 4°C, sonicated, and
centrifuged. Protein concentration was determined by detergent-
compatible assay (DC assay; Bio-Rad). 20S Proteasome purification
and quantification by sandwich ELISA assay were performed as
previously described (Fabre et al, 2013). Briefly, for 20S proteasome
purification, each cell lysate sample was incubated with 100 mg of
CNBr sepharose beads (GE Healthcare) coupled with 0.8 mg MCP21
antibody (directed against the a2 subunit of the 20S proteasome).
Supernatants (S1) were collected, and beads were washed three
times with 40 bead volumes of washing buffer (20 mM Tris–HCl pH 8,
1 mM EDTA, 10% glycerol, 150 mM NaCl, 0.1% NP-40, 10 mM
ATP and 2 mM MgCl2), and proteins were eluted with 0.5 ml of
elution buffer (20 mM Tris–HCl pH 8, 1 mM EDTA, 10% glycerol,
3 M NaCl, 10 mM ATP and 2 mM MgCl2). Beads were then washed
and incubated with supernatants S1. Two additional cycles of purifi-
cation were repeated, and the three eluates were finally pooled
together.
Fractionation of proteasome complexes by glycerol
gradient sedimentation
2 × 108 U937 cross-linked cells were lysed with 2 ml of lysis buffer
and centrifuged at 14,000 g for 10 min. Samples were concentrated
to a final volume of 500 ll using an ultrafiltration device with a
cutoff of 100 kDa (Millipore). Samples were then fractionated by
15–40% (v/v) (100 mM Tris–HCl pH 7.4, 0.15 M NaCl, 0.5 M
MgCl2, 2 mM ATP, 15–40% glycerol) linear glycerol density gradi-
ent ultra-centrifugation (22 h; 96,500 g) using a Beckman SW 28
rotor. The gradient was separated into 32 fractions of 1 ml. Protea-
some activity was measured in each fraction as previously
described (Fabre et al, 2013). The 19 fractions (corresponding to
glycerol percentages of 24–40%) where proteasomal activity was
detected were used for the LC-MS/MS and PCP analyses. 1% of
each glycerol gradient fraction was used for LC-MS/MS analysis.
Before injection on the nano-LC, eight isotopically labeled peptides
(AQUA peptides) eluting all along the chromatographic gradient
were spiked (100 fmol of each peptide per injection) to normalize
the MS inter-run signal intensity variations.
Detailed LC-MS/MS analysis, data search, and validation
Each purified proteasome sample or glycerol gradient fraction was
precipitated with 20% TCA and washed with acetone. Samples
were boiled 30 min at 95°C in Laemmli buffer to denature proteins
and reverse formaldehyde cross-link, as previously optimized
(Fabre et al, 2013). Proteins were alkylated with 100 mM chloro-
acetamide for 30 min at room temperature in the dark. Proteins
were concentrated in a single band on a 12% acrylamide
SDS–PAGE gel and visualized by colloidal Coomassie Blue staining.
One-shot analysis of the entire mixture was performed. A single
band, containing the whole sample, was cut and washed in 50 mM
ammonium bicarbonate for 15 min at 37°C followed by a second
wash in 50 mM ammonium bicarbonate, acetonitrile (1:1) for
15 min at 37°C, and a final dehydration in 100% ACN. Trypsin
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(Promega) digestion was performed over night at 37°C. The result-
ing peptides were extracted from the gel by three steps: a first incu-
bation in 50 mM ammonium bicarbonate for 15 min at 37°C and
two incubations in 10% formic acid, acetonitrile (1:1) for 15 min at
37°C. The three collected extractions were pooled with the initial
digestion supernatant, dried in a Speed-Vac, and resuspended with
2% acetonitrile, 0.05% trifluoroacetic acid. The peptides mixtures
were analyzed by nano-LC-MS/MS using an UltiMate 3000 system
(Dionex) coupled to LTQ-Orbitrap XL or Velos mass spectrometers
(Thermo Fisher Scientific, Bremen, Germany). Five microliters of
each peptide sample corresponding to an equivalent initial quantity
of 20S proteasome (estimated by Elisa) of 2.5 lg for purified
proteasome samples or 5 lg of total proteins for the glycerol gradi-
ent fractions were loaded on a C18 precolumn (300 lm inner diam-
eter × 5 mm; Dionex) at 20 ll/min in 5% acetonitrile, 0.05%
trifluoroacetic acid. After 5 min of desalting, the precolumn was
switched online with the analytical C18 column (75 lm inner diam-
eter × 15 cm; PepMap C18, Dionex) equilibrated in 95% solvent A
(5% acetonitrile, 0.2% formic acid) and 5% solvent B (80% aceto-
nitrile, 0.2% formic acid). Peptides were eluted using a 5–50%
gradient of solvent B during 160 min at a 300 nl/min flow rate.
The LTQ-Orbitrap XL was operated in data-dependent acquisition
mode with the Xcalibur software. Survey scan MS spectra were
acquired in the Orbitrap on the 350–1,800 m/z range with the reso-
lution set to a value of 60,000. The five (LTQ-Orbitrap XL) or
twenty (LTQ-Orbitrap Velos) most intense ions per survey scan
were selected for CID fragmentation, and the resulting fragments
were analyzed in the linear trap (LTQ). Dynamic exclusion was
used within 60 s to prevent repetitive selection of the same peptide.
The Mascot Daemon software (version 2.3.2; Matrix Science,
London, UK) was used to perform database searches, using the
Extract_msn.exe macro provided with Xcalibur (version 2.0 SR2;
Thermo Fisher Scientific) to generate peaklists. The following
parameters were set for creation of the peaklists: parent ions in the
mass range 400–4,500, no grouping of MS/MS scans, and threshold
at 1,000. A peaklist was created for each analyzed fraction, and
individual Mascot (version 2.3.01) searches were performed for
each fraction. The mass tolerances in MS and MS/MS were set to
5 ppm and 0.8 Da, respectively, and the instrument setting was
specified as ‘ESI-TRAP’. Trypsin was designated as the protease
(specificity set for cleavage after Lys or Arg), and up to two missed
cleavages were allowed. Oxidation of methionine and amino-termi-
nal protein acetylation were searched as variable modifications.
Carbamidomethylation on cysteine was set as fixed modification.
Protein hits were automatically validated with a false discovery rate
(FDR) of 1% on proteins and 5% on peptides (minimum peptide
length of 6 amino acids). To evaluate false-positive rates, all the
initial database searches were performed using the ‘decoy’ option
of Mascot, that is, the data were searched against a combined data-
base containing the real specified protein sequences (target data-
base, Swiss-Prot human, release 2013_01, 20,232 entries) and the
corresponding reversed protein sequences (decoy database).
Mascot file parsing and quantification (MFPaQ) used the same
criteria to validate decoy and target hits, calculated the false discov-
ery rate [FDR = number of validated decoy hits/(number of vali-
dated target hits + number of validated decoy hits) × 100]. Proteins
identified with exactly the same set of peptides were grouped, and
only one member of the protein group was reported (the one that
we considered as the most significant according to the functional
description given in the UniProt Knowledgebase). Highly homolo-
gous protein hits, that is, proteins identified with top ranking MS/MS
queries also assigned to another protein hit of higher score (red,
non-bold peptides), were detected by the MFPaQ software
(Mouton-Barbosa et al, 2010) and were considered as individual
hits and included in the final list only if they were additionally
assigned a specific top ranking (red and bold) peptide of score
higher than 30 (P-value < 0.05).
Data quantification
Relative quantification of proteins
Quantification of proteins was performed using the label-free
module implemented in the MFPaQ v4.0.0 software (http://
mfpaq.sourceforge.net/) (Bouyssie et al, 2007; Mouton-Barbosa
et al, 2010; Gautier et al, 2012). For each sample, the software uses
the validated identification results and extracts ion chromatograms
(XIC) of the identified peptide ions in the corresponding raw nano-
LC-MS files, based on their experimentally measured retention time
(RT) and monoisotopic m/z values. The time value used for this
process is retrieved from Mascot result files, based on an MS2 event
matching to the peptide ion. If several MS2 events were matched to
a given peptide ion, the software checks the intensity of each corre-
sponding precursor peak in the previous MS survey scan. The time
of the MS scan, which exhibits the highest precursor ion intensity, is
attributed to the peptide ion and then used for XIC extraction as well
as for the alignment process. Peptide ions identified in all the
samples to be compared were used to build a retention time matrix
in order to align LC-MS runs. If some peptide ions were sequenced
by MS/MS and validated only in some of the samples to be
compared, their XIC signal was extracted in the nano-LC-MS raw file
of the other samples using a predicted RT value calculated from this
alignment matrix by a linear interpolation method. Quantification of
peptide ions was performed based on calculated XIC areas values.
Only peptides with a Mascot score higher than 30 (P-value < 0.05)
at least in one of the samples were selected for the quantification. In
order to perform protein relative quantification in different samples,
a protein abundance index (PAI) was calculated. It is defined as the
average of XIC area values for the most three intense reference tryp-
tic peptides identified for this protein (the three peptides exhibiting
the highest intensities across the different samples were selected as
reference peptides, and these same three peptides were used to
compute the PAI of the protein in each sample; if only one or two
peptides were identified and quantified in the case of low-abundant
proteins, the PAI was calculated based on their XIC area values).
Protein correlation profiling analysis
Glycerol sedimentation profiles were normalized by dividing the
protein abundance index of each protein in each fraction of the
gradient by the sum of the protein abundance indexes measured in
all the gradient fractions. v2 values were calculated between the
profiles of all the proteins identified and quantified in the glycerol
gradient fractions and the reference proteins profiles with the
formula v2 ¼ Ri xi  xp
 2
=xpÞ in which i is the fraction number, xi
is the normalized value in fraction i, and xp is the value of the refer-
ence protein in fraction i, as described previously (Wiese et al,
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2007). The sedimentation profiles of the median of the non-catalytic
20S proteasome subunits (a1–a7, b3, b4, b6 and b7), the median of
19S subunits, and the median of the PA28ab were used as reference
profiles. The v2 values of the two biological replicates were plotted
for each chosen reference.
Supervised and unsupervised clustering of proteins abundances
across 24 affinity-purified proteasomes samples
The supervised clustering was performed based on the R2 values
(Coefficient of determination) obtained from the pairwise compari-
son of the abundances (PAIs), across the 24 proteasome purifica-
tions, of proteasome subunits or known interacting proteins with
the abundances (PAIs) of eight reference proteasome sub-complexes
or regulators. The PAIs of these eight references were calculated as
follows:
• PAI of the 20S non-catalytic proteasome (ncP20S): median PAIs of
subunits a1–a7, b3, b4, b6 and b7
• PAI of the standard proteasome (sP20S): PAI of subunit b5
• PAI of the immunoproteasome (iP20S): PAI of subunit b2i
• PAI of the 19S RP: median PAIs of subunits Rpt1–6 and
Rpn1,2,3,5,6,7,8,9,10,11,12,13
• PAI of the PA28ab RP: median PAIs of subunits PA28a and PA28b
• PA28c, PA200, and PI31 are formed by a unique polypeptide
chain, so their PAIs were directly used.
The heat-map was created using the R package software (version
3.1.0) and the graphic package ggplot2 (version 0.9.3.1).
The two unsupervised clustering analyses (principal component
analysis, PCA, and agglomerative hierarchical clustering, AHC) were
performed from normalized PAIs, across the 24 proteasome purifica-
tions, of proteasome subunits or known interacting proteins using
the XLSTAT software (version 2012.3.01). The PAIs were normal-
ized by setting the highest PAI measured for a given protein in the
proteasome purifications to one. The PCA was of Pearson (n) type.
For the AHC, the Pearson correlation coefficient was used to search
for similarities using an unweighted pair-group average agglomera-
tion method.
Data availability
The mass spectrometry proteomics data have been deposited to the
ProteomeXchange Consortium (Vizcaino et al, 2014) via the PRIDE
partner repository with the dataset identifier PXD001043 (Supple-
mentary Table S8).
Supplementary information for this article is available online:
http://msb.embopress.org
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